share_log

Apellis Pharmaceuticals | 144/A: Others

SEC announcement ·  Oct 10, 2023 09:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more